• Most Popular
  • Most Shared

Keryx: Panel says drug candidate doesn't raise safety concerns

Thu Dec 6, 2007 8:13am EST

Stocks

   

Dec 6 (Reuters) - Keryx Biopharmaceuticals (KERX.O) said an independent data safety monitoring committee (DSMC) found no safety concerns regarding Keryx's lead drug candidate, Sulonex, for the treatment of diabetic nephropathy.

Stocks  |  Regulatory News

The company said the DSMC had found no reason to recommend alteration or termination of the late-stage trial. The main goal of the late-stage trial is "therapeutic success" at six months.

Diabetic nephropathy is a complication of diabetes in which the kidneys are progressively damaged. (Reporting by Neha Pathania in Bangalore; Editing by Amitha Rajan)

Stocks
Regulatory News


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets